Petros Pharmaceuticals, Inc. (PTPI)

Data as of Jun 8, 2026, from SEC Form 4 filings.

No open-market insider trades (90d)Watch PTPI

See up to 3 months of PTPI. The 7-day demo opens the 1M and 3M ranges and puts PTPI on your watchlist.

Latest PTPI insider trades

Wayne Remell Walker - Director
Grant or award375,000 sh
Jun 5, 2026
Fady Boctor - Officer
Grant or award375,000 sh
Jun 5, 2026
Bruce Bernstein - Director

About Petros Pharmaceuticals, Inc. (PTPI)

The SEC lists Petros Pharmaceuticals, Inc. under CIK 0001815903, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.

Sector: Health Care

SEC filings for PTPI on EDGAR

PTPI Form 4 activity by transaction type, last 90 days

No Form 4 activity for PTPI in the last 90 days.

PTPI insider transactions (Form 4)

4 Form 4 filings on record, the earliest from Jun 5, 2026, newest first.

Date	Insider	Transaction	Security	Shares	Price	Value
Jun 5, 2026	Wayne Remell Walker - Director	Grant or award	Common Stock	375,000^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Represents restricted shares ("Shares") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing… Full note on SEC EDGAR
Jun 5, 2026	Fady Boctor - Officer	Grant or award	Common Stock	375,000^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Represents restricted shares ("Shares") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing… Full note on SEC EDGAR
Jun 5, 2026	Bruce Bernstein - Director	Grant or award	Common Stock	1,875,000^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Represents restricted shares ("Shares") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing… Full note on SEC EDGAR
Jun 5, 2026	Joshua Silverman - Director	Grant or award	Common Stock	4,375,000^{footnote F1}	$0.00^{footnote F1}	-
Footnote F1 (price, shares): Represents restricted shares ("Shares") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing… Full note on SEC EDGAR

Recent PTPI Form 8-K filings

Read PTPI company news

Sep 30, 2026Item 1.03, 2.04, 5.02

Read the filing on SEC EDGAR

Jun 18, 2026Item 5.02, 9.01

Read the filing on SEC EDGAR

PTPI insider trading FAQ

What is the latest insider trade for PTPI?

Petros Pharmaceuticals, Inc. (PTPI) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-08. The full record for PTPI runs to 4 Form 4 filings, the earliest from 2026-06-05. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying PTPI stock?

No insider purchases of PTPI were filed in the last 90 days.

How many insiders are selling PTPI stock?

No insider sales of PTPI were filed in the last 90 days.

Where can I see PTPI SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects PTPI Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Jun 8, 2026 - Wayne Remell Walker view on EDGAR
Jun 5, 2026 - Fady Boctor view on EDGAR
Jun 5, 2026 - Bruce Bernstein view on EDGAR
Jun 5, 2026 - Joshua Silverman view on EDGAR

Related companies with recent insider activity

Learn more

What the Form 4 transaction codes mean: Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
Insider activity in Health Care: Where PTPI's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow PTPI with a 7-day demo

PTPI on your watchlist
Every PTPI Form 4 filing on record
Up to 3 months of PTPI price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Date

Insider

Transaction

Security

Price

Value

Jun 5, 2026

Wayne Remell Walker - Director

Grant or award

Common Stock

375,000^{footnote F1}

$0.00^{footnote F1}

Footnote F1 (price, shares): Represents restricted shares ("Shares") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing… Full note on SEC EDGAR

Jun 5, 2026

Fady Boctor - Officer

Grant or award

Common Stock

375,000^{footnote F1}

$0.00^{footnote F1}

Footnote F1 (price, shares): Represents restricted shares ("Shares") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing… Full note on SEC EDGAR

Jun 5, 2026

Bruce Bernstein - Director

Grant or award

Common Stock

1,875,000^{footnote F1}

$0.00^{footnote F1}

Footnote F1 (price, shares): Represents restricted shares ("Shares") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing… Full note on SEC EDGAR

Jun 5, 2026

Joshua Silverman - Director

Grant or award

Common Stock

4,375,000^{footnote F1}

$0.00^{footnote F1}

Footnote F1 (price, shares): Represents restricted shares ("Shares") of common stock, par value $0.0001 per share, of the Issuer. 50% of the Shares vested on the date of grant and the remaining 50% will vest on the six-month anniversary of the date of grant, provided that the Reporting Person is providing… Full note on SEC EDGAR